There is no single “CRISPR patent.” Instead, other organizations own several patents related to different aspects of the CRISPR/Cas9 system.
For example, the Broad Institute (a research institute affiliated with MIT and Harvard) holds patents on CRISPR in eukaryotic cells. In contrast, the University of California, Berkeley holds patents on using CRISPR in bacteria and archaea.